Figure 1
From: A circulating miRNA assay as a first-line test for prostate cancer screening
Boxplots of the distribution of –ΔΔCt values for circulating miR-20a, miR-21, miR-93, miR-106a, miR-130b and miR-223 in patients with localised PCa vs biopsy-negative individuals. Each dot represents a patient sample. –ΔΔCt values (see Materials and methods) were calculated using endogenous miR-24 as a reference. Differences between BIO+ and BIO− samples were analysed using two-tailed Wilcoxon rank-sum test. miR-106a, miR-223, miR-20a and miR-21 showed P-values<0.05.
